Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?

被引:0
作者
G Grazzini
C B Visioli
M Zorzi
S Ciatto
F Banovich
A G Bonanomi
A Bortoli
G Castiglione
L Cazzola
M Confortini
P Mantellini
T Rubeca
M Zappa
机构
[1] ISPO Cancer Prevention and Research Institute Florence,Department of Screening
[2] Venetian Tumour Registry,undefined
[3] Istituto Oncologico Veneto Via Gattamelata 64,undefined
[4] Local Health Unit no. 4,undefined
[5] Veneto Region,undefined
[6] Local Health Unit no. 22,undefined
[7] Veneto Region,undefined
[8] Local Health Unit no. 2,undefined
[9] Veneto Region,undefined
来源
British Journal of Cancer | 2009年 / 100卷
关键词
immunochemical test; colorectal neoplasms; faecal occult blood test; screening; cutoff;
D O I
暂无
中图分类号
学科分类号
摘要
Immunochemical faecal occult blood tests have shown a greater sensitivity than guaiac test in colorectal cancer screening, but optimal number of samples and cutoff have still to be defined. The aim of this multicentric study was to evaluate the performance of immunochemical-based screening strategies according to different positivity thresholds (80, 100, 120 ng ml−1) and single vs double sampling (one, at least one, or both positive samples) using 1-day sample with cutoff at 100 ng ml−1 as the reference strategy. A total of 20 596 subjects aged 50–69 years were enrolled from Italian population-based screening programmes. Positivity rate was 4.5% for reference strategy and 8.0 and 2.0% for the most sensitive and the most specific strategy, respectively. Cancer detection rate of reference strategy was 2.8‰, and ranged between 2.1 and 3.4‰ in other strategies; reference strategy detected 15.6‰ advanced adenomas (range=10.0–22.5‰). The number needed to scope to find a cancer or an advanced adenoma was lower than 2 (1.5–1.7) for the most specific strategies, whereas it was 2.4–2.7, according to different thresholds, for the most sensitive ones. Different strategies seem to have a greater impact on adenomas rather than on cancer detection rate. The study provides information when deciding screening protocols and to adapt them to local resources.
引用
收藏
页码:259 / 265
页数:6
相关论文
共 118 条
[1]  
Castiglione G(2002)Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood J Med Screen 9 99-103
[2]  
Grazzini G(2000)Screening for colorectal cancer by faecal occult blood test: comparison of immunochemical tests J Med Screen 7 35-37
[3]  
Miccinesi G(1997)Cost analysis in a population-based screening programme for colorectal cancer: comparison of immunochemical and guaiac faecal occult blood testing J Med Screen 4 142-146
[4]  
Rubeca T(2007)Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16) J Med Screen 14 191-199
[5]  
Sani C(2005)Screening for colorectal cancer using faecal blood testing: varying the positive cut-off value Pathology 37 565-568
[6]  
Turco P(2005)The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial J Med Screen 12 83-88
[7]  
Zappa M(2007)Estimates of the cancer incidence and mortality in Europe in 2006 Ann Oncol 18 581-592
[8]  
Castiglione G(2007)Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population Gut 56 210-214
[9]  
Zappa M(2008)Diagnostic accuracy of immunochemical faecal occult blood tests according to number of samples and positivity threshold J Med Screen 1 48-49
[10]  
Grazzini G(2007)Screening for colorectal cancer using the faecal occult blood test, Hemoccult Cochrane Database Syst Rev 1 CD001216-71